公司资料

Y-mAbs 股价、新闻与催化剂

股票代码:: YMAB
交易所:: NASDAQ
行业:: Biopharma
所在地:: United States

股价为何变动

Current closing-price context is not available for YMAB.

公司概览

业务概览

Y-mAbs Therapeutics is an oncology and rare-disease company focused on antibody-based therapies. Its platform has been built around highly specific biologic treatments for difficult diseases.

所在地与行业分类

Headquartered in the United States and listed on NASDAQ, Y-mAbs sits in specialty biotechnology.

商业模式特征

The company depends on product adoption, clinical progress, and the expansion of its antibody franchise.

生物医药行业定位

Y-mAbs is a focused antibody biotech whose stock reacts to data, adoption, and label progress.

未来催化剂

Y-mAbs’s catalysts are DANYELZA sales, pediatric-oncology expansion, and any follow-on immunotherapy update. The key question is whether the GD2 franchise can keep compounding.